title: [Surgical treatment of pancreatic metastases from renal carcinoma].
abstract: OBJECTIVE
  Pancreatic metastases from renal carcinoma are poorly known. The aim of this study was to report clinical and radiological manifestations, the treatment performed, and the observed survival in 7 patients with this rare entity.
  
  
  RESULTS
  All patients were operated on. One patient had nonresectable tumor. Six patients underwent curative resection. There was one postoperative death. Follow-up after pancreatectomy ranged from 6 months to 3 years. Two patients developed extra-pancreatic metastases one year and 3 years after pancreatectomy respectively.
  
  
  CONCLUSIONS
  Pancreatic metastases from renal carcinoma are rare and often occur several years after nephrectomy. However their resection is often possible and allows a good long-term survival.
  
  
  METHODS
  From 1988 to 2000, 7 patients (5 men and 2 women, mean age = 66 years) with pancreatic metastases from a renal cell carcinoma were observed in the same center. One patient had synchronous metastasis; in the 6 others, metastases were diagnosed 4 to 16 years after nephrectomy, and were revealed by pain (n = 2), gastrointestinal bleeding (n = 1), faintness (n = 1) or routine follow-up (n = 2). The diagnosis of metastases was made by contrast-enhanced abdominal CT-scan.
authors.affiliation: Service de chirurgie digestive, thoracique et cancérologique, Hôpital du Bocage, 2, Boulevard Maréchal-de-Lattre-de-Tassigny, BP 1542, 21034 Dijon, France.
authors.forename: F
authors.initials: F
authors.lastname: Peschaud
authors.forename: N
authors.initials: N
authors.lastname: Cheynel
authors.forename: O
authors.initials: O
authors.lastname: Hagry
authors.forename: J C
authors.initials: JC
authors.lastname: Tremeaux
authors.forename: P
authors.initials: P
authors.lastname: Rat
authors.forename: J P
authors.initials: JP
authors.lastname: Favre
mesh_terms: D015746:Abdominal Pain / Q000209:etiology; D018262:Adenocarcinoma, Clear Cell / Q000175:diagnosis / Q000401:mortality / Q000556:secondary* / Q000601:surgery*; D000328:Adult; D000368:Aged; D002292:Carcinoma, Renal Cell / Q000175:diagnosis / Q000401:mortality / Q000556:secondary* / Q000601:surgery*; D002758:Cholangiography; D005260:Female; D005500:Follow-Up Studies; D006471:Gastrointestinal Hemorrhage / Q000209:etiology; D006801:Humans; D007680:Kidney Neoplasms / Q000473:pathology* / Q000601:surgery; D008279:Magnetic Resonance Imaging; D008297:Male; D008875:Middle Aged; D009367:Neoplasm Staging; D009392:Nephrectomy; D010166:Palliative Care; D010180:Pancreatectomy / Q000009:adverse effects / Q000379:methods*; D010190:Pancreatic Neoplasms / Q000175:diagnosis / Q000401:mortality / Q000556:secondary* / Q000601:surgery*; D015996:Survival Rate; D013575:Syncope / Q000209:etiology; D013997:Time Factors; D014057:Tomography, X-Ray Computed; D016896:Treatment Outcome